Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Morbidity and mortality associated with obesity.

Abdelaal M, le Roux CW, Docherty NG.

Ann Transl Med. 2017 Apr;5(7):161. doi: 10.21037/atm.2017.03.107. Review.

2.

Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways.

Lew JK, Pearson JT, Schwenke DO, Katare R.

Cardiovasc Diabetol. 2017 Jan 13;16(1):10. doi: 10.1186/s12933-016-0484-4. Review.

3.

Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study).

Htike ZZ, Yates T, Brady EM, Webb D, Gray LJ, Swarbrick D, McCann GP, Khunti K, Davies MJ.

Cardiovasc Diabetol. 2016 Jul 21;15(1):102. doi: 10.1186/s12933-016-0421-6.

4.

Impaired cerebral blood flow and oxygenation during exercise in type 2 diabetic patients.

Kim YS, Seifert T, Brassard P, Rasmussen P, Vaag A, Nielsen HB, Secher NH, van Lieshout JJ.

Physiol Rep. 2015 Jun;3(6). pii: e12430. doi: 10.14814/phy2.12430.

5.

Type 2 diabetes mellitus and exercise impairment.

Reusch JE, Bridenstine M, Regensteiner JG.

Rev Endocr Metab Disord. 2013 Mar;14(1):77-86. doi: 10.1007/s11154-012-9234-4. Review.

6.

Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?

Oghlakian GO, Sipahi I, Fang JC.

Mayo Clin Proc. 2011 Jun;86(6):531-9. doi: 10.4065/mcp.2010.0841. Epub 2011 May 16. Review.

7.

Diastolic dysfunction is associated with sedentary leisure time physical activity and smoking in females only.

Bennet L, Larsson C, Söderström M, Råstam L, Lindblad U.

Scand J Prim Health Care. 2010 Sep;28(3):172-8. doi: 10.3109/02813432.2010.506803.

8.

Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis.

von Bibra H, St John Sutton M.

Diabetologia. 2010 Jun;53(6):1033-45. doi: 10.1007/s00125-010-1682-3. Epub 2010 Mar 30. Review.

9.

Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Huynh K, McMullen JR, Julius TL, Tan JW, Love JE, Cemerlang N, Kiriazis H, Du XJ, Ritchie RH.

Diabetes. 2010 Jun;59(6):1512-20. doi: 10.2337/db09-1456. Epub 2010 Mar 9.

10.

Left ventricular function and exercise capacity.

Grewal J, McCully RB, Kane GC, Lam C, Pellikka PA.

JAMA. 2009 Jan 21;301(3):286-94. doi: 10.1001/jama.2008.1022.

Supplemental Content

Support Center